NAP1L1 interacts with HDGF, and the latter recruits c-Jun, a key oncogenic transcription factor, thereby inducing CCND1/CDK4/CDK6 expressions and promoting proliferation and chemoresistance in glioma cells. The gene discussed is CCND1; the disease is central nervous system cancer.